Alyeska Investment Group
BIOA

Alyeska Investment Group’s BioAmber Inc. BIOA Stock Holding History

Alyeska Investment Group’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-56,706
Closed -$427K – 520
2015
Q3 		$303K Sell
56,706
-55,337
-49% -$365K ﹤0.01% 440
2015
Q2 		$964K Buy
+112,043
New +$1.02M 0.01% 409
2014
Q2 		– Sell
-128,109
Closed -$1.32M – 484
2014
Q1 		$1.47M Sell
128,109
-16,891
-12% -$200K 0.04% 277
2013
Q4 		$1.08M Hold
145,000
– – 0.04% 263
2013
Q3 		$711K Hold
145,000
– – 0.03% 276
2013
Q2 		$986K Buy
+145,000
New +$1.08M 0.05% 242

Other funds holding BIOA

WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
NIPH
NN Investment Partners Holdings The Hague, Netherlands $18.6B AUM 18.31% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RS
Robeco Schweiz Zurich, Switzerland $6.23B AUM 86.54% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return

Alyeska Investment Group's BIOA Position: Q4 2015 in Review

Alyeska Investment Group sold out of BioAmber Inc. (BIOA) in Q4 2015, closing a stake of 56,706 shares — an estimated $427K sold.

Alyeska Investment Group first reported a position in BIOA in Q2 2013 and held it in 6 quarters. The position peaked at $1.47M in Q1 2014. 35 funds tracked by Wall St. Rank hold BIOA as of Q4 2015.

  • Alyeska Investment Group reported no remaining BioAmber Inc. position as of Q4 2015 after selling out during the quarter.
  • Alyeska Investment Group sold 56,706 BioAmber Inc. shares in Q4 2015, an estimated $427K.
  • Alyeska Investment Group first reported a position in BioAmber Inc. in Q2 2013 and held it in 6 quarters.
  • Alyeska Investment Group's BioAmber Inc. position peaked at $1.47M in Q1 2014.
  • 35 funds tracked by Wall St. Rank held BioAmber Inc. as of Q4 2015.

Based on Alyeska Investment Group's 13F filing for Q4 2015, filed 16 Feb 2016.